ATOSSA THERAPEUTICS INC. - COMMON STOCK
0.8374
31-January-25 15:52:40
15 minutes delayed
Stocks
-0.0279
-3.22%
Today's range
0.8299 - 0.9179
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months Low: ATOSSA THERAPEUTICS INC. - COMMON STOCK
30 Jan 2025 09:45:02 By NetDania Notify
-
30 Jan 2025 08:17:09 By Nasdaq GlobeNewswire
-
23 Jan 2025 08:15:00 By Nasdaq GlobeNewswire
-
06 Jan 2025 09:00:00 By Nasdaq GlobeNewswire
-
11 Dec 2024 08:15:00 By Nasdaq GlobeNewswire
-
10 Dec 2024 09:05:00 By Nasdaq GlobeNewswire
-
09 Dec 2024 08:15:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present Poster on (Z)-Endoxifen at AACR Special Conference in Cancer Research
21 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
20 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
12 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
05 Nov 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
04 Nov 2024 06:30:00 By Nasdaq GlobeNewswire
-
31 Oct 2024 08:15:00 By Nasdaq GlobeNewswire
-
21 Oct 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit
14 Oct 2024 17:08:43 By Nasdaq GlobeNewswire
-
01 Oct 2024 08:30:00 By Nasdaq GlobeNewswire
-
10 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
28 Aug 2024 08:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >